GTGabriel Torrealba-Acosta

Gabriel Torrealba-Acosta

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Gabriel Torrealba-Acosta has a total of 147 co-authors. Here are the top co-authors by number of shared publications:

  • Ana Gorostidi-Pagola

    Department of Neurology and Neurosurgery, Baylor College of Medicine, Houston, TX, United States

    2 shared publications
  • Eric Yu

    Montreal Neurological Institute and Hospital, McGill University, Montreal, QC, Canada

    2 shared publications
  • Ignacio F. Mata

    Department of Neurology and Neurosurgery, Baylor College of Medicine, Houston, TX, United States

    2 shared publications
  • Jaime Fornaguera-Trías

    Neurosciences Research Center, Universidad de Costa Rica, San José, Costa Rica

    2 shared publications
  • Javier Ruíz-Martínez

    Department of Neurology and Neurosurgery, Baylor College of Medicine, Houston, TX, United States

    2 shared publications
  • Jean-François Trempe

    Department of Neurology and Neurosurgery, Baylor College of Medicine, Houston, TX, United States

    2 shared publications

Latest Publications

  • Clinical Reasoning: A 28-Year-Old Man With Seizures and Thalamic Lesions

    by Ana B. Santos-Rojo, Anthony Hong-Lo, Georgina Toledo-Rosello, Christopher Eckstein, Suma Shah, Nicholas Turner, Anne F. Buckley, Cherylee W.J. Chang, Gabriel Torrealba-Acosta

    This case involves a 28-year-old Black man who presented with new-onset seizures and bilateral medial temporal lobe hyperintensities on brain MRI, initially raising concern for viral encephalitis. ...

  • Open Access

    Multifactorial Cardiovascular Risk Control and All-cause Mortality in Older Adults: A Pooled Cohort Study from Costa Rica, Mexico, and the UK

    by Javier Calvo-Marín, Jesus Alegre-Díaz, Victoria Mora-Gomez, Francis Ruiz-Salazar, Kenneth Ernest-Suarez, Roberto Tapia-Conyer, Pablo Kuri, Gabriel Torrealba-Acosta

    Background: Comprehensive control of cardiovascular risk factors (CVRFs) is a cornerstone of preventive care, yet its combined impact on long-term mortality in older adults across diverse populations remains insufficiently characterised. We aimed to evaluate the association between multifactorial cardiovascular risk control and 10-year all-cause mortality in older adults from three countries. Methods: We conducted a pooled cohort study including 91,990 adults aged 65 years and older from Costa Rica, Mexico, and the UK. Six CVRFs (blood pressure, lipids, glycaemic status, body-mass index, smoking, and physical activity) were assessed and categorised as controlled or not controlled. Participants were grouped according to the number of controlled CVRFs (0–5). The primary outcome was 10-year all-cause mortality. Multivariable Cox proportional hazards models were used to estimate adjusted hazard ratios (HRs) and 95% CIs. Findings: During follow-up, 14,440 (15·7%) deaths occurred. A graded inverse association was observed between the number of controlled CVRFs and mortality risk. Compared with participants with no controlled factors, adjusted HRs were 0·86 (95% CI 0·79–0·93) for one factor, 0·75 (0·69–0·81) for two, 0·64 (0·59–0·69) for three, 0·56 (0·51–0·62) for four, and 0·41 (0·34–0·50) for five controlled factors. Among individual components, physical activity (HR 0·80, 95% CI 0·76–0·84) and non-smoking (0·81, 0·79–0·84) showed the strongest associations with lower mortality risk, whereas lipid control was not associated with reduced risk. Interpretation: Greater multifactorial control of cardiovascular risk factors is strongly and progressively associated with lower mortality in older adults. These findings support integrated prevention strategies that simultaneously target multiple risk factors to improve survival in ageing populations.

  • Open Access

    Disparities in acute stroke care delivery: equality or equity from stroke systems improvement?

    by Matthew E Ehrlich, Gabriel Torrealba-Acosta, Carmelo Graffagnino, Lisa Monk, Edwin Iversen, Brad J Kolls

  • Open Access

    What OPTIMISTmain Teaches About Margins, Imputation, and Interpretation

    by Gabriel Torrealba-Acosta, Ravi Garg, Pitchaiah Mandava

    OPTIMISTmain was a clinical trial examining low-intensity post-thrombolysis monitoringcompared to standard monitoring in patients with acute ischemic stroke. This article examinesthe clinical trial’s data management, alongside the study’s statistical analysis plan, and reportedanalytical results offering stroke clinicians insight into non-inferiority trial interpretation andreadiness for practice implementation.


  • Identifying a proteomics signature of cognitive impairment and dementia in blood and cerebrospinal fluid through a mediation analysis framework

    by Gabriel Torrealba-Acosta, Shu Yang, Javier Calvo-Marín, Abhay R Moghekar, Aida Kamalian, Michael W Lutz, Alzheimer’S Disease Neuroimaging Initiative

  • Open Access

    Checklist conundrum: are we checking the right boxes?

    by Gabriel Torrealba-Acosta, César E Escamilla-Ocañas


  • Open Access

    A methodological assessment of randomization integrity in alteplase for acute ischemic stroke individual patient data meta-analyses

    by Ravi Garg, Gabriel Torrealba-Acosta, Steffen Mickenautsch, Vance W. Berger

    Objectives: Little is known about the integrity of randomization for randomized controlled trials (RCT) included in alteplase for stroke meta-analyses. If the RCTs were not properly randomized, the results could not be accepted at face value. The objective was to assess the integrity of randomization in individual patient data (IPD) meta-analyses supporting alteplase for acute ischemic stroke. Methods: We assessed randomization reporting, performed qualitative risk of bias assessments arising from the randomization process, and performed fixed effects meta-analyses of baseline variables for which zero heterogeneity is expected if all included RCTs have unbiased randomization. Fixed-effects meta-analyses of baseline age, weight, and National Institute of Health Stroke Scale (NIHSS) score were performed. If heterogeneity was present (I2 > 0%), trials were systematically removed, starting with the RCT with the largest t-statistic until the I2 value was 0%. Results: The NINDS rt-PA Stroke Study had a high risk of bias, the ECASS-3 RCT had some concerns, and all other trials were graded as low risk according to the Cochrane Risk of Bias (ROB-2) tool. The NINDS rt-PA Stroke Study contributed to heterogeneity in age and weight meta-analyses, and the ECASS-3 RCT contributed to heterogeneity in the NIHSS score meta-analysis. Removal of suspect trials resulted in the expected I2 value of 0%. Conclusions: The NINDS rt-PA Stroke Study and ECASS-3 trials contributed to heterogeneity in fixed effects meta-analyses of baseline variables while there should have been none. These RCTs are likely a source of selection bias in IPD meta-analyses due to suspect randomization.

  • Open Access

    Sex differences in the diagnosis latency of Parkinson's disease in Latin America

    by Janvi Ramchandra, Miguel Inca-Martinez, Thiago Peixoto Leal, Henry Mauricio Chaparro-Solano, Amira Salim, Emilia M. Gatto, Natalia González Rojas, Gustavo Da Prat, Federico Micheli, Bruno Lopes Santos-Lobato, et al.


  • Open Access

    Corrigendum: Clinical and genetic analysis of Costa Rican patients with Parkinson's disease

    by Gabriel Torrealba-Acosta, Eric Yu, Tanya Lobo-Prada, Javier Ruíz-Martínez, Ana Gorostidi-Pagola, Ziv Gan-Or, Kenneth Carazo-Céspedes, Jean-François Trempe, Ignacio F. Mata, Jaime Fornaguera-Trías

    Corrigendum: Clinical and genetic analysis of Costa Rican patients with Parkinson's disease

  • Open Access

    Implementation of systematic safety checklists in a neurocritical care unit: a quality improvement study

    by César E Escamilla-Ocañas, Gabriel Torrealba-Acosta, Pitchaiah Mandava, Muhammad Suhaib Qasim, Bárbara Gutiérrez-Flores, Eric Bershad, Mohammad Hirzallah, Chethan P Venkatasubba Rao, Rahul Damani

    Background and objectives Structured and systematised checklists have been shown to prevent complications and improve patient care. We evaluated the implementation of systematic safety checklists in our neurocritical care unit (NCCU) and assessed its effect on patient outcomes. Design/methods This quality improvement project followed a Plan–Do–Study–Act (PDSA) methodology. A checklist for medication reconciliation, thromboembolic prophylaxis, glycaemic control, daily spontaneous awakening, breathing trial, diet, catheter/lines duration monitoring and antibiotics de-escalation was implemented during daily patient rounds. Main outcomes included the rate of new infections, mortality and NCCU-length of stay (LOS). Intervened patients were compared with historical controls after propensity score and Euclidean distance matching to balance baseline covariates. Results After several PDSA iterations, we applied checklists to 411 patients; the overall average age was 61.34 (17.39). The main reason for admission included tumour resection (31.39%), ischaemic stroke (26.76%) and intracerebral haemorrhage (10.95%); the mean Sequential Organ Failure Assessment (SOFA) score was 2.58 (2.68). At the end of the study, the checklist compliance rate throughout the full NCCU stays reached 97.11%. After controlling for SOFA score, age, sex and primary admitting diagnosis, the implementation of systematic checklists significantly correlated with a reduced LOS (ß=−0.15, 95% CI −0.24 to −0.06), reduced rate of any new infections (OR 0.59, 95% CI 0.40 to 0.87) and reduced urinary tract infections (UTIs) (OR 0.23, 95% CI 0.09 to 0.55). Propensity score and Euclidean distance matching yielded 382 and 338 pairs with excellent covariate balance. After matching, outcomes remained significant. Discussion The implementation of safety checklists in the NCCU proved feasible, easy to incorporate into the NCCU workflow, and a helpful tool to improve adherence to practice guidelines and quality of care measurements. Furthermore, our intervention resulted in a reduced NCCU-LOS, rate of new infections and rate of UTIs compared with propensity score and Euclidean distance matched historical controls.